ORUM
🇰🇷XKOS.475830South KoreaHealthcare
Price₩25,000.00-400.00 (-1.57%)
Latest anomalies
Very negative 3 detected in the last 120 days
- High: 2
- Medium: 2
- Low: 0
Volume: a spike above the 20-day average
Daily return: an extreme move down, far outside its trailing 60-day range
Overnight gap: a gap down from the prior close
Debt to equity: rose sharply against the prior quarter
Free with a Finzer account.
Profile
- Healthcare
- Biotechnology
- South Korea
Identity
- Exchange
- KOSDAQ . XKOS
- Type
- Stock
- ISIN
- KR7475830006
- CUSIP
- Not reported
Company
- Employees
- 21
- Headquarters
- Daejeon, South Korea
- Website
- https://www.orumrx.com
Market
- Shares outstanding
- 21.2M
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- Not reported
- Net income
- Not reported
- Gross margin
- Not reported
- Free cash flow
- Not reported
Latest news
News is not sourced for this exchange.
Business summary
ORUM is a company in the healthcare sector, listed on KOSDAQ (South Korea) under the ticker 475830. Across the 240 trading sessions to the shares traded between ₩24,450.00 and ₩146,600.00, and the last close of ₩25,000.00 sits 0% of the way up that range. The company is headquartered in Daejeon, South Korea, and employs about 21 people.
Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases. The company focuses on degrader-antibody conjugate that combine antibody-drug conjugate with targeted protein degradation technology. Its lead product candidate is ORM-1153, a GSPT1 protein degrader that targets hematologic malignancies. The company was founded in 2016 and is based in Daejeon, South Korea.